Worth reading
31Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Incoming appointee
1 itemScheduled Appointment DateEffective 1 April 2026
Hirata Tomohiro (平田 知広)
New positionExecutive Officer, Production Business Headquarters; President of 森六ReNova㈱
Departing officer
1 itemDate of departure1 April 2026 (departure from the executive officer position)
Koiwai Muga (小岩井 無我), Shinmura Atsushi (新村 篤史)Next role stated
Former PositionExecutive officers
New positionKoiwai Muga (小岩井 無我): Special Projects; Shinmura Atsushi (新村 篤史): General Manager, Life Science Department, Chemical Business Headquarters
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Whether he will remain on the Board of Directors: Not disclosed
| Item | Details |
|---|---|
| Scheduled Appointment Date | Effective 1 April 2026 |
| Date of departure | 1 April 2026 (departure from the executive officer position) |
| Name of appointee | Hirata Tomohiro (平田 知広) |
| Appointee's new position | Executive Officer, Production Business Headquarters; President of 森六ReNova㈱ |
| Name of departing officer | Koiwai Muga (小岩井 無我), Shinmura Atsushi (新村 篤史) |
| Former position of departing officer | Executive officers |
| New position of departing officer | Koiwai Muga (小岩井 無我): Special Projects; Shinmura Atsushi (新村 篤史): General Manager, Life Science Department, Chemical Business Headquarters |
| Whether the incumbent will remain in office | Whether he will remain on the Board of Directors: Not disclosed |
Items this document does not state (13)
Resolution dateAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company has not provided a specific explanation for the change.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.